12 Chamber Intermittent Pneumatic Compression (IPC) System
Hydroven® 12, with its unique LymphAssist™ mode, is an advanced Intermittent Pneumatic Compression (IPC) system which has been designed to offer both clinicians and patients an effective treatment option to manage lymphedema.
Developed in conjunction with Manual Lymphatic Drainage (MLD) therapists, Lymphedema Specialists and Tissue Viability nurses, Hydroven 12 delivers a gentle and effective treatment for your patients.
In addition to the management of lymphatic conditions, Hydroven 12 is effective in the treatment of the following conditions, when combined with an individualized monitoring program:
- • Acute and chronic wound management
- • Chronic venous insufficiency
- • Edema management
Choice of three Automatic Treatment Profiles
The Hydroven 12 system is comprised of an intelligent pump and a range of multi-chamber arm and leg garments capable of delivering three types of treatment options.
Graduated Sequential Therapy
The graduated sequential therapy provides a controlled pressure differential between adjacent chambers in each garment. This therapy helps restore the natural hydrostatic balance of the limb being treated.
Wave therapy produces a gentle peristaltic cycle for those patients who may be unable to tolerate graduated sequential compression.
The flexibility of this ‘three-in-one’ approach provides clinicians with the confidence that the treatment can be tailored to suit the clinical indications and patient’s requirements. Each profile allows clinicians to optimize pressure settings and treatment times to deliver the most effective treatment for managing vascular conditions
LymphAssist™ therapy – Exclusive to Hydroven
The unique LymphAssist mode replicates the basic principles of Manual Lymph Drainage (MLD). The automatic pressure and multi-chamber sequencing helps to promote efficient fluid transfer through the patient’s lymphatic system.
This gentle ‘directional’, rhythmic massaging stimulates the lymphatic vessels encouraging the transport of proteins and waste products away from affected areas.
Clinical evidence – Intermittent Pneumatic Compression (IPC) and Manual Lymph Drainage (MLD) provide a synergistic enhancement of the effect of Complex Decongestive Physiotherapy (CDP).
IPC can be used safely and effectively for the treatment of patients with breast carcinoma associated Lymphedema. The ease of application of IPC as a long term therapeutic intervention suggest that it may warrant more widespread use in this patient population. The therapy is well tolerated and remarkably free from complications.